Created projects

Live projects

No projects found.

Draft projects

No projects found.

Pending Projects

No projects found.

Membership Projects

No projects found.

Suspended Projects

No projects found.

Expired Projects

    No projects found.

view all

You are logged in as Log out

Anthony Sterns, Ph.D.

Chief Executive Officer

iRxReminder LLC

Cleveland, Ohio United States

Hospital and Health Care, Cleveland/Akron, Ohio Area

CUNY SPS, UMUC, University of Akron

About Me

Anthony Sterns founded iRxReminder after 10-years of research on caring for people living with dementia. The key lesson gained from this work is that people lose their independence due to failing to take their medications correctly. In addition, healthcare professionals are disconnected from what their patients are experiencing and cannot share their expertise and help. iRxReminder's core purpose is to empower patients and healthcare professionals to manage medications together, to achieve high adherence, and to provide effortless clinical monitoring to enable timely interventions that lower ER visits, and improve health outcomes. Dr. Sterns is a recognized national expert in the area of gerontechnology and a pioneer in the application of mobile computers and smartphones for improving the quality of life for individuals living with chronic illness. Dr. Sterns has over 20 years experience in designing and bringing to market products and services for the silver industries marketplace. He is a member of the APA Division 20 board and a Fellow of the Gerontological Society of America. Dr. Sterns is a board member of the International Society of Gerontechnology where he also serves as the Deputy Secretary General and as an Associate Editor for the Society’s journal, Gerontechnology. Dr. Sterns has led National Institutes of Health grants and contracts in the development of software for medication adherence on mobile devices since 2001. His direct project experience includes serving as the principal investigator developing a post-transient ischemic attack (mini-stroke) intervention (NIH 1R43AG033500) and working on two projects with co-investigator Dr. Hughes on a management of congenital heart failure intervention (NIH 1R43AG042230) and a medication adherence system that uses artificial intelligence to monitor Tardive Dyskinesia delivered using smartphones (NIH 1R43MH114763).